SCHEDULE 13G 0001634113 XXXXXXXX LIVE Ordinary Shares, no par value 08/14/2025 0002029039 Nasus Pharma Ltd. M7071P109 Yigal Alon 65 Tel Aviv L3 6744317 Rule 13d-1(c) Capital Point Ltd. b L3 575129 0 575129 0 575129 N 6.35 CO With regard to Rows (5), (7) and (9), please see Item 4. Row (11) is based on 9,059,635 ordinary shares issued and outstanding as of August 13, 2025 (as provided by the Issuer). Nasus Pharma Ltd. Yigal Alon 65, Tel Aviv, Israel, 6744317 Capital Point Ltd. Azrieli 1, Tel Aviv 67021, Israel Israel Y See Row 9 of cover page of the reporting person. . See Row 11 of cover page of the reporting person. See Row 5 of cover page of the reporting person. See Row 6 of cover page of the reporting person. See Row 7 of cover page of the reporting person. See Row 8 of cover page of the reporting person. Y Y Y Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. Capital Point Ltd. /s/ Avi Katzav 08/20/2025 /s/ Yossi Tamar 08/20/2025